BACKGROUND/AIMS: The transmembrane glycoprotein osteoactivin is expressed in osteoblasts, dendritic cells and tumor cells. It is suggested to influence osteoblast maturation, cell adhesion and migration. We studied osteoactivin expression within the liver. METHODS: Expression of osteoactivin was analysed by RT-PCR, Northern blotting, in situ hybridisation (ISH) and immunohistochemistry (IHC) comparing normal and acutely injured rat liver [induced by carbon tetrachloride (CCl(4)) administration], liver cell populations, and normal or diseased human liver. RESULTS: By ISH osteoactivin expression was detected in sinusoid-lining cells found by IHC to be positive for the common mononuclear phagocyte marker antibody anti-CD68. While total liver contained only traces, isolated Kupffer cells expressed abundant amounts of osteoactivin mRNA further increasing during culture. In acutely injured rat liver osteoactivin expression was strongly increased reaching maximum of expression 48h after CCl(4). By ISH osteoactivin expression was localised in pericentral inflammatory cells and sinusoid-lining cells again anti-CD68 positive. Dexamethasone and lipopolysaccharide decreased osteoactivin expression in cultured mononuclear phagocytes of normal as well as of acutely injured liver. In human liver osteoactivin was increased in fulminant hepatitis and paracetamol intoxication. CONCLUSIONS: Osteoactivin is expressed at high levels in normal and inflammatory liver macrophages suggesting a significant role in acute liver injury.
BACKGROUND/AIMS: The transmembrane glycoprotein osteoactivin is expressed in osteoblasts, dendritic cells and tumor cells. It is suggested to influence osteoblast maturation, cell adhesion and migration. We studied osteoactivin expression within the liver. METHODS: Expression of osteoactivin was analysed by RT-PCR, Northern blotting, in situ hybridisation (ISH) and immunohistochemistry (IHC) comparing normal and acutely injured rat liver [induced by carbon tetrachloride (CCl(4)) administration], liver cell populations, and normal or diseased human liver. RESULTS: By ISH osteoactivin expression was detected in sinusoid-lining cells found by IHC to be positive for the common mononuclear phagocyte marker antibody anti-CD68. While total liver contained only traces, isolated Kupffer cells expressed abundant amounts of osteoactivin mRNA further increasing during culture. In acutely injured rat liver osteoactivin expression was strongly increased reaching maximum of expression 48h after CCl(4). By ISH osteoactivin expression was localised in pericentral inflammatory cells and sinusoid-lining cells again anti-CD68 positive. Dexamethasone and lipopolysaccharide decreased osteoactivin expression in cultured mononuclear phagocytes of normal as well as of acutely injured liver. In human liver osteoactivin was increased in fulminant hepatitis and paracetamol intoxication. CONCLUSIONS:Osteoactivin is expressed at high levels in normal and inflammatory liver macrophages suggesting a significant role in acute liver injury.
Authors: M Liguori; E Digifico; A Vacchini; R Avigni; F S Colombo; E M Borroni; F M Farina; S Milanesi; A Castagna; L Mannarino; I Craparotta; S Marchini; E Erba; N Panini; M Tamborini; V Rimoldi; P Allavena; C Belgiovine Journal: Cell Mol Immunol Date: 2020-07-29 Impact factor: 11.530
Authors: Matilda H-C Sheng; Jon E Wergedal; Subburaman Mohan; Mehran Amoui; David J Baylink; K-H William Lau Journal: PLoS One Date: 2012-04-20 Impact factor: 3.240
Authors: Adamantios Michalinos; Alexandra K Tsaroucha; Maria Lambropoulou; Dimitrios Schizas; Georgia Valsami; Nikolaos Kostomitsopoulos; Michael S Pitiakoudis; Constantinos E Simopoulos Journal: Transl Gastroenterol Hepatol Date: 2020-01-05
Authors: Kenneth S Kompass; Olga A Agapova; Wenjun Li; Paul L Kaufman; Carol A Rasmussen; M Rosario Hernandez Journal: BMC Neurosci Date: 2008-09-26 Impact factor: 3.288